Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes

Immunology Letters

Volumn 146, Issue 1-2, 2012, Pages 50-56

  Najar, Mehdi ^a   Raicevic, Gordana ^a   Jebbawi, Fadi ^a   De Bruyn, Cécile ^a   Meuleman, Nathalie ^a   Bron, Dominique ^a   Toungouz, Michel ^a   Lagneaux, Laurence ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

CD200; CD200R; Immunomodulation; Mesenchymal stromal cells; Source types; T cell subsets

Indexed keywords

CD200 ANTIGEN; CD200 RECEPTOR; CELL MARKER; GAMMA INTERFERON;

ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL INTERACTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STROMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR BINDING; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; WHARTON JELLY;

ADIPOSE TISSUE; ANTIGENS, CD; ANTIGENS, SURFACE; BONE MARROW; CELL COMMUNICATION; CELL PROLIFERATION; COCULTURE TECHNIQUES; GENE EXPRESSION; HUMANS; INTERFERON-GAMMA; MESENCHYMAL STROMAL CELLS; ORGAN SPECIFICITY; PRIMARY CELL CULTURE; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; WHARTON JELLY;

EID: 84864118749     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2012.04.017     Document Type: Article

References (64)

1. Friedenstein A.J., Petrakova K.V., Kurolesova A.I., Frolova G.P. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968, 6:230-247.
2. Tondreau T., Meuleman N., Delforge A., Dejeneffe M., Leroy R., Massy M., et al. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells 2005, 23(8):1105-1112.
3. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001, 7(2):211-228.
4. Campagnoli C., Roberts I.A., Kumar S., Bennett P.R., Bellantuono I., Fisk N.M. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001, 98:2396-2402.
5. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
6. Keating A. Mesenchymal stromal cells. Curr Opin Hematol 2006, 13:419-425.
7. Arthur A., Zannettino A., Gronthos S. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J Cell Physiol 2009, 218:237-245.
8. Mosna F., Sensebé L., Krampera M. Human bone marrow and adipose tissue mesenchymal stem cells: a user's guide. Stem Cells Dev 2010, 19:1449-1470.
9. Fan C.G., Zhang Q.J., Zhou J.R. Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev 2011, 7:195-207.
10. Marigo I., Dazzi F. The immunomodulatory properties of mesenchymal stem cells. Semin Immunopathol 2011, 33:593-602.
11. Najar M., Raicevic G., Boufker H.I., Fayyad Kazan H., De Bruyn C., Meuleman N., et al. Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: combined comparison of adipose tissue: Wharton's Jelly and bone marrow sources. Cell Immunol 2010, 264:171-179.
12. Najar M., Raicevic G., Boufker H.I., Fayyad-Kazan H., De Bruyn C., Meuleman N., et al. Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor. Tissue Eng Part A 2010, 16:3537-3546.
13. Dazzi F., Krampera M. Mesenchymal stem cells and autoimmune diseases. Best Pract Res Clin Haematol 2011, 24:49-57.
14. Kebriaei P., Robinson S. Treatment of graft-versus-host-disease with mesenchymal stromal cells. Cytotherapy 2011, 13:262-268.
15. Nathan C., Muller W.A. Putting the brakes on innate immunity: a regulatory role for CD200. Nat Immunol 2001, 2:17-19.
16. Gorczynski R.M., Hadidi S., Yu G., Clark D.A. The same immunoregulatory molecules contribute to successful pregnancy and transplantation. Am J Reprod Immunol 2002, 48:18-26.
17. Rosenblum M.D., Olasz E.B., Yancey K.B., Woodliff J.E., Lazarova Z., Gerber K.A., et al. Expression of CD200 on epithelial cells of the murine hair follicle: a role in tissue-specific immune tolerance. J Invest Dermatol 2004, 123:880-887.
18. Clark D.A. Tolerance signaling molecules. Chem Immunol Allergy 2005, 89:36-48.
19. Najar M., Raicevic G., Id Boufker H., Stamatopoulos B., De Bruyn C., Meuleman N., et al. Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions. Exp Hematol 2010, 38:922-932.
20. De Bruyn C., Najar M., Raicevic G., Meuleman N., Pieters K., Stamatopoulos B., et al. A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment. Stem Cells Dev 2011, 20:547-557.
21. Horwitz E.M., Le Blanc K., Dominici M., Mueller I., Slaper-Cortenbach I., Marini F.C., et al. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy 2005, 7:393-395.
22. Avanzini M.A., Bernardo M.E., Cometa A.M., Perotti C., Zaffaroni N., Novara F., et al. Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors. Haematologica 2009, 94:1649-1660.
23. Jansen B.J., Gilissen C., Roelofs H., Schaap-Oziemlak A., Veltman J.A., Raymakers R.A., et al. Functional differences between mesenchymal stem cell populations are reflected by their transcriptome. Stem Cells Dev 2010, 19:481-490.
24. McCaughan G.W., Clark M.J., Hurst J., Grosveld F., Barclay A.N. The gene for MRC OX-2 membrane glycoprotein is localized on human chromosome 3. Immunogenetics 1987, 25:133-135.
25. Gorczynski R.M., Cattral M.S., Chen Z., Hu J., Lei J., Min W.P., et al. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival. J Immunol 1999, 163:1654-1660.
26. Barclay A.N., Wright G.J., Brooke G., Brown M.H. CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol 2002, 23:285-290.
27. Kelly O.G., Chan M.Y., Martinson L.A., Kadoya K., Ostertag T.M., Ross K.G., et al. Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells. Nat Biotechnol 2011, 29:750-756.
28. Ko Y.C., Chien H.F., Jiang-Shieh Y.F., Chang C.Y., Pai M.H., Huang J.P., et al. Endothelial CD200 is heterogeneously distributed, regulated and involved in immune cell-endothelium interactions. J Anat 2009, 214:183-195.
29. Uccelli A., Pistoia V., Moretta L. Mesenchymal stem cells: a new strategy for immunosuppression. Trends Immunol 2007, 28:219-226.
30. Haynesworth S.E., Baber M.A., Caplan A.I. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J Cell Physiol 1996, 166:585-592.
31. Hwa Cho H., Bae Y.C., Jung J.S. Role of toll-like receptors on human adipose-derived stromal cells. Stem Cells 2006, 24:2744-2752.
32. Pevsner-Fischer M., Zipori D. Environmental signals regulating mesenchymal progenitor cell growth and differentiation. Regulatory Networks in Stem Cells 2009, 175-184. Humana Press, New York. V.K. Rajasekhar, M.C. Vemuri (Eds.).
33. Chen Z., Marsden P.A., Gorczynski R.M. Role of a distal enhancer in the transcriptional responsiveness of the human CD200 gene to interferon-gamma and tumor necrosis factor-alpha. Mol Immunol 2009, 46:1951-1963.
34. Chtanova T., Tangye S.G., Newton R., Frank N., Hodge M.R., Rolph M.S., et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol 2004, 173:68-78.
35. Dorfman D.M., Shahsafaei A. CD200 (OX-2 membrane glycoprotein) is expressed by follicular T helper cells and in angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 2011, 35:76-83.
36. Dimeloe S, Richards DF, Urry ZL, Gupta A, Stratigou V, Farooque S, Saglani S, Bush A, Hawrylowicz CM. 1α,25-Dihydroxyvitamin D3 promotes CD200 expression by human peripheral and airway-resident T cells. Thorax. 2012 Feb 14. [Epub ahead of print].
37. Bain C.C., Mowat A.M. CD200 receptor and macrophage function in the intestine. Immunobiology 2012, 217:643-651.
38. Wright G.J., Jones M., Puklavec M.J., Brown M.H., Barclay A.N. The unusual distribution of the neuronal/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans. Immunology 2001, 102:173-179.
39. Le Blanc K., Rasmusson I., Götherström C., Seidel C., Sundberg B., Sundin M., et al. Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand J Immunol 2004, 60:307-315.
40. Groh M.E., Maitra B., Szekely E., Koç O.N. Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol 2005, 33:928-934.
41. Prasanna S.J., Gopalakrishnan D., Shankar S.R., Vasandan A.B. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One 2010, 5:e9016.
42. Razmkhah M., Jaberipour M., Erfani N., Habibagahi M., Talei A.R., Ghaderi A. Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-β1 and upregulate expression of regulatory molecules on T cells: do they protect breast cancer cells from the immune response. Cell Immunol 2011, 266:116-122.
43. Kim K.D., Zhao J., Auh S., Yang X., Du P., Tang H., et al. Adaptive immune cells temper initial innate responses. Nat Med 2007, 13:1248-1252.
44. Holt P.G., Strickland D.H. The CD200-CD200R axis in local control of lung inflammation. Nat Immunol 2008, 9:1011-1013.
45. Fanchiang S.S., Cojocaru R., Othman M., Khanna R., Brooks M.J., Smith T., et al. Global expression profiling of peripheral Qa-1-restricted CD8αα+TCRαβ+regulatory T cells reveals innate-like features: implications for immune-regulatory repertoire. Hum Immunol 2012, 73:214-222.
46. Wright G.J., Cherwinski H., Foster-Cuevas M., Brooke G., Puklavec M.J., Bigler M., et al. Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J Immunol 2003, 171:3034-3046.
47. Gorczynski R.M. CD200 and its receptors as targets for immunoregulation. Curr Opin Investig Drugs 2005, 6:483-488.
48. Rijkers E.S., de Ruiter T., Baridi A., Veninga H., Hoek R.M., Meyaard L. The inhibitory CD200R is differentially expressed on human and mouse T and B lymphocytes. Mol Immunol 2008, 45:1126-1135.
49. Saldanha-Araujo F., Ferreira F.I., Palma P.V., Araujo A.G., Queiroz R.H., Covas D.T., et al. Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes. Stem Cell Res 2011, 7:66-74.
50. Wang X.B., Fan Z.Z., Anton D., Vollenhoven A.V., Ni Z.H., Chen X.F., et al. CTLA4 is expressed on mature dendritic cells derived from human monocytes and influences their maturation and antigen presentation. BMC Immunol 2011, 12:21.
51. Seeds R.E., Gordon S., Miller J.L. Characterisation of myeloid receptor expression and interferon alpha/beta production in murine plasmacytoid dendritic cells by flow cytometry. J Immunol Methods 2009, 350:106-117.
52. Krejsek J., Kolackova M., Mandak J., Kunes P., Jankovicova K., Vlaskova D., et al. Expression of CD200/CD200R regulatory molecules on granulocytes and monocytes is modulated by cardiac surgical operation. Perfusion 2010, 25:389-397.
53. Darmochwal-Kolarz D., Kludka-Sternik M., Serafin A., Kolarz B., Rolinski J., Oleszczuk J. The expressions of CD200 and CD200R on antigen presenting cells in cord blood of healthy neonates. Arch Perinat Med 2011, 17:44-48.
54. Minas K., Liversidge J. Is the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal. Crit Rev Immunol 2006, 26:213-230.
55. Clark D.A., Chaouat G., Wong K., Gorczynski R.M., Kinsky R. Tolerance mechanisms in pregnancy: a reappraisal of the role of class I paternal MHC antigens. Am J Reprod Immunol 2010, 63:93-103.
56. Gorczynski R., Khatri I., Lee L., Boudakov I. An interaction between CD200 and monoclonal antibody agonists to CD200R2 in development of dendritic cells that preferentially induce populations of CD4+CD25+T regulatory cells. J Immunol 2008, 180:5946-5955.
57. Gorczynski L., Chen Z., Hu J., Kai Y., Lei J., Ramakrishna V., et al. Evidence that an OX-2-positive cell can inhibit the stimulation of type 1 cytokine production by bone marrow-derived B7-1 (and B7-2)-positive dendritic cells. J Immunol 1999, 162:774-781.
58. Fallarino F., Asselin-Paturel C., Vacca C., Bianchi R., Gizzi S., Fioretti M.C., et al. Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J Immunol 2004, 173:3748-3754.
59. Coles S.J., Wang E.C., Man S., Hills R.K., Burnett A.K., Tonks A., et al. CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia. Leukemia 2011, 25:792-799.
60. Gorczynski R.M., Chen Z., Clark D.A., Kai Y., Lee L., Nachman J., et al. Structural and functional heterogeneity in the CD200R family of immunoregulatory molecules and their expression at the feto-maternal interface. Am J Reprod Immunol 2004, 52:147-163.
61. Hatherley D., Barclay A.N. The CD200 and CD200 receptor cell surface proteins interact through their N-terminal immunoglobulin-like domains. Eur J Immunol 2004, 34:1688-1694.
62. Lee L., Liu J., Manuel J., Gorczynski R.M. A role for the immunomodulatory molecules CD200 and CD200R in regulating bone formation. Immunol Lett 2006, 105:150-158.
63. Jenmalm M.C., Cherwinski H., Bowman E.P., Phillips J.H., Sedgwick J.D. Regulation of myeloid cell function through the CD200 receptor. J Immunol 2006, 176:191-199.
64. Simelyte E., Alzabin S., Boudakov I., Williams R. CD200R1 regulates the severity of arthritis but has minimal impact on the adaptive immune response. Clin Exp Immunol 2010, 162:163-168.